Get the app!
Back to Trades
Sell4

TENET HEALTHCARE CORP

THC

Total Value
$2.9M
Net $1.9M sold
Sales
$1.9M
3 transactions

Company Information

Ticker Symbol
THC
CIK
0000070318

Insider Information

Role
Insider
Location
DALLAS, TX

Filing Details

Filing Date
Mar 3, 2026
Transaction Date
Feb 27, 2026
Accession Number
0001193125-26-089412
Form Type
4
Net Trading Amount
-$1.9M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Feb 27, 2026Common Stock934Exercise
Feb 27, 2026Common Stock1,400Exercise
Feb 27, 2026Common Stock175$237.58Tax Withholding$41.6K
Feb 27, 2026Common Stock919$239.39Tax Withholding$220.0K
Feb 27, 2026Common Stock3,114$239.39Tax Withholding$745.5K
Mar 2, 2026Common Stock2,125$230.98Sale$490.8K
Mar 2, 2026Common Stock4,494$233.21Sale$1.0M
Mar 2, 2026Common Stock1,398$233.69Sale$326.7K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Feb 27, 2026Derivative934Exercise
Feb 27, 2026Derivative1,400Exercise

Footnotes

  1. (F1)Restricted stock units convert into common stock on a one-for-one basis.
  2. (F2)Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units.
  3. (F3)Represents the closing price of the common stock of the Issuer on the vesting date for the award.
  4. (F4)Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
  5. (F5)Represents the closing price of the common stock of the Issuer on February 27, 2026.
  6. (F6)The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 28, 2024, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment vested on February 27, 2026 (the business day prior to February 28, 2026, which fell on a weekend).
  7. (F7)Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.
  8. (F8)The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the third 1/3 increment vested on February 27, 2026 (the business day prior to March 1, 2026, which fell on a weekend).
  9. (F9)The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $230.78 to $231.68.
  10. (F10)The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $232.52 to $233.32.
  11. (F11)The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $233.60 to $234.28.
  12. (F12)The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.